[1] |
袁强,杜丹. 复杂性肾结石的微创治疗新进展[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(2): 136-138.
|
[2] |
Hamamoto S, Yasui T, Okada A, et al. Endoscopic combined intrarenal surgery for large calculi: simultaneous use of flexible ureteroscopy and mini-percutaneous nephrolithotomy overcomes the disadvantageous of percutaneous nephrolithotomy monotherapy[J]. J Endourol, 2014, 28(1): 28-33.
|
[3] |
Turk C, Petrik A, Sarica K, et al. EAU Guidelines on interventional treatment for urolithiasis[J]. Eur Urol,2016,69(3):475-482.
|
[4] |
Liang T, Zhao C, Wu G, et al. Multi-tract percutaneous nephrolithotomy combined with EMS lithotripsy for bilateral complex renal stones: our experience[J]. BMC Urol, 2017, 17(1): 15.
|
[5] |
Zhao Z, Cui Z, Zeng T, et al. Comparison of 1-stage with 2-stage multiple-tracts mini-percutaneous nephrolithotomy for the treatment of staghorn stones: a matched cohorts analysis[J]. Urology, 2016, 87: 46-51.
|
[6] |
Mutlu B, Ilbey YO, Bitkin A, et al. Abdominoscrotal hydrocele with bilateral hydronephrosis in an adult: case report[J]. Arch Ital Urol Androl, 2013, 85(1): 44-46.
|
[7] |
赖德辉,李逊,何永忠, 等. 二期微创经皮肾镜联合输尿管软镜处理孤立肾鹿角状结石[J]. 现代泌尿外科杂志, 2016, 21(7): 537-540.
|
[8] |
Akman T, Sari E, Binbay M, et al., Comparison of outcomes after percutaneous nephrolithotomy of staghorn calculi in those with single and multiple accesses[J]. J Endourol, 2010, 24(6): 955-960.
|
[9] |
Cho HJ, Lee JY, Kim SW, et al. Percutaneous nephrolithotomy for complex renal calculi: is multi-tract approach ok? [J]. Can J Urol, 2012, 19(4): 6360-6565.
|
[10] |
Hegarty NJ, Desai MM. Desai, Percutaneous nephrolithotomy requiring multiple tracts: comparison of morbidity with single-tract procedures[J]. J Endourol, 2006, 20(10): 753-760.
|
[11] |
Domingueti CP, Fóscolo RB, Lms D, et al. Association of different biomarkers of renal function with D-dimer levels in patients with type 1 diabetes mellitus (renal biomarkers and D-dimer in diabetes)[J].Archi Endocrinol Metab, 2018, 62(1): 27-33.
|
[12] |
Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9): 604-612.
|
[13] |
全国eGFR课题协作组. MDRD方程在我国慢性肾脏病患者中的改良和评估[J]. 中华肾脏病杂志, 2006, 22(10): 589-595.
|
[14] |
Ismail OZ, Bhayana V, Kadour M, et al. Improving the translation of novel biomarkers to clinical practice: the story of cystatin c implementation in canada: a professional practice column[J]. Clin Biochem, 2017, 50(7-8): 380-384.
|
[15] |
晁流,刘宁,甘卫东, 等. 保留肾单位术与根治性肾切除术对肾功能影响的比较[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2017, 11(6): 393-397.
|
[16] |
Kashani K, Cheungpasitporn W, Ronco C. Biomarkers of acute kidney injury: the pathway from discovery to clinical adoption[J]. Clin Chem Lab Med, 2017, 55(8): 1074-1089.
|
[17] |
付玉华,菅建国. 血尿素氮、血肌酐与血清胱抑素C联合检测对肾功能损害程度的诊断价值研究[J]. 中国疗养医学, 2017, 26(5): 466-468.
|
[18] |
陈瑞阳. 缬沙坦对原发性高血压合并2型糖尿病患者血压及肾功能的影响[J]. 医药论坛杂志, 2016, 37(8): 147-149.
|
[19] |
魏丽丽. 血清胱抑素C在高血压患者肾功能评价中的应用[J]. 中华高血压杂志, 2014, 9(1): 79-81.
|